scholarly journals Ductal carcinoma in situ in the elderly: what is the ideal treatment plan?

2019 ◽  
Vol 2019 ◽  
Author(s):  
Cosette A. DeChant ◽  
Samantha M. Thomas ◽  
Laura H. Rosenberger ◽  
Oluwadamilola M. Fayanju ◽  
Rachel A. Greenup ◽  
...  
2014 ◽  
Vol 12 ◽  
pp. S47-S49 ◽  
Author(s):  
Giuseppe Falco ◽  
Nicola Rocco ◽  
Eugenio Procaccini ◽  
Maria Giulia Sommella ◽  
Daniele Bordoni ◽  
...  

Rare Tumors ◽  
2012 ◽  
Vol 4 (4) ◽  
pp. 169-171 ◽  
Author(s):  
Takanobu Sato ◽  
Akira Iwasaki ◽  
Takeo Iwama ◽  
Shigeo Kawai ◽  
Tsuyoshi Nakagawa ◽  
...  

We report a very rare case of extensive ductal carcinoma in situ (DCIS) of the breast with secretory features in a 30-year old Japanese woman. The patient presented with a nodule in the lower inner quadrant of the left breast measuring approximately 2–3 cm, accompanied by an irregular tumor shadow with segmental microcalcification on mammography. These findings suggested malignancy, and excisional biopsy was performed following core needle biopsy. Pathological diagnosis was that of DCIS with secretory features. A treatment plan of simple mastectomy and sentinel lymph node biopsy was chosen. Most previous reports have only described invasive secretory carcinoma of the breast. We have only been able to find 2 case reports of non-invasive secretory lesion in the English literature to date. Because the characteristics of this lesion are not widely known, we thought it important to share our findings.


2017 ◽  
Vol 58 (12) ◽  
pp. 1434-1441 ◽  
Author(s):  
Soo Heui Baek ◽  
Woo Jung Choi ◽  
Joo Hee Cha ◽  
Hak Hee Kim ◽  
Hee Jung Shin ◽  
...  

Background The ability to accurately assess tumor size in ductal carcinoma in situ (DCIS) is an important clinical issue when selecting the appropriate treatment plan. Purpose To compare the accuracy of using mammography, ultrasound (US), and magnetic resonance imaging (MRI) to assess DCIS tumor size based on imaging and histopathological findings. Material and Methods Fifty-six patients with DCIS were included. Mammography, US, and MRI were reviewed, and the accuracy of the measured tumor sizes were compared with the imaging and histopathological parameters. Results If visible, tumor measurements demonstrated high reliability with the pathologically determined size, with the best results obtained using US ( k = 0.851) followed by mammography ( k = 0.815) and MRI ( k = 0.738). Tumor size assessment was significantly more accurate when the lesion was shown as a mass on US ( P = 0.003) or MRI ( P < 0.001) with minimal and mild background parenchymal enhancement ( P = 0.016) on MRI. When mammography was used to assess tumor size, the tumors with positive estrogen receptor status and luminal A subtype demonstrated a significantly more accurate tumor size. Conclusion The combination of US and MRI, in addition to mammography, has an important role in assessing the exact tumor extent of DCIS.


1999 ◽  
Vol 41 (6) ◽  
pp. 1225
Author(s):  
Eung Yeop Kim ◽  
Boo Kyung Han ◽  
Yeon Hyeon Choe ◽  
Seok Jin Nam ◽  
Young Hyeh Ko ◽  
...  

2019 ◽  
Author(s):  
Gemma M Wilson ◽  
Barbara J Guild ◽  
Christine L Clarke ◽  
Nirmala Pathmanathan ◽  
J Dinny Graham

Sign in / Sign up

Export Citation Format

Share Document